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FAILURE OF AN IMPLANTABLE LEFT VENTRICULAR ASSIST DEVICE: A DISTINCTIVE
ELECTROCARDIOGRAPHIC PATTERN BEFORE MALFUNCTION
William Piccione, Jr., MD,a Walter G. Kao, MD,b Annette Mattea, RN, BSN,b E. Rene Rodriguez, MD,c and
Richard G. Trohman, MD,b Chicago, Ill.
Long-term implantable left ventricular assist devices
(LVADs) have revolutionized the care of patients with
heart failure who are awaiting transplantation.1, 2 The
HeartMate Vented Electric (VE) (Thermo Cardiosystems
Inc., Woburn, Mass.) Left Ventricular Assist System
(LVAS) consists of an implanted LVAD with a percuta-
neous drive line that connects the internal pump to the
external power supply and controller, as well as providing
a vent for the internal chamber to the atmosphere. The
system is capable of supplying full circulatory support for
the left ventricle and is currently being evaluated both as
a bridge to transplantation and as a permanent alternative
to transplantation in patients with irreversible heart fail-
ure.
We report a case of primary pump failure that was
heralded by a distinctive pattern on the electrocardiogram
(ECG). Although device-related failures with currently
available implantable LVADs have been extremely un-
common, we believe the ECG findings described, which
occurred before device failure, may serve a predictive
function and thereby avoid a catastrophic outcome.
Clinical summary. The patient was a 60-year-old man
who had an acute anterior wall myocardial infarction
approximately 4 months before evaluation at our institu-
tion. Despite timely thrombolytic therapy and urgent
coronary balloon angioplasty of an occluded left anterior
descending coronary artery, the infarction progressed and
the patient was left with severe residual left ventricular
dysfunction, with an estimated left ventricular ejection
fraction of approximately 20% by radionuclide ventricu-
lography. After his referral to our institution, he was
rehospitalized on two subsequent occasions for decom-
pensated heart failure, which was responsive only to
parenteral inotropic agents and diuretics. Despite aggres-
sive medical support, his hemodynamic status continued
to deteriorate and he was listed for heart transplantation.
Seven months after the infarction, right heart catheteriza-
tion revealed the following pressures while the patient was
maintained on a continuous milrinone infusion: right
atrium 8 mm Hg, pulmonary artery 75/39 mm Hg (mean
55 mm Hg), pulmonary artery wedge 40 mm Hg, cardiac
index 1.3 L z min z m2, and systemic blood pressure 75/50
mm Hg. The patient was judged to have heart failure
refractory to maximal medical therapy and the decision
was made to proceed with implantation of an LVAD as a
bridge to transplantation. The patient’s blood type was
O1 and the preoperative panel reactive antibody level
was 68%.
The device was implanted in the standard fashion with
the LVAD positioned in a preperitoneal subcostal pocket
with the inflow catheter placed in the left ventricular apex
and the outflow graft anastomosed to the proximal as-
cending aorta. The combined power and control cable
exited percutaneously above the left iliac crest in the left
lower quadrant of the abdomen. The postoperative course
was unremarkable and the patient quickly resumed his
preoperative activity level with physical therapy. Antico-
agulation consisted of 325 mg of aspirin per day. LVAD
flow rates remained at 5 to 6 L/min off all cardiac
medications. Renal and pulmonary function remained
normal.
On postoperative day 82, the patient reported a vague
feeling of generalized uneasiness, and the LVAD flow
rates indicated on the external console demonstrated a
decrease to approximately 3 L/min. Systemic blood pres-
sure remained within normal ranges. An intravenous
bolus of normal saline solution was administered, after
which the LVAD flow rates returned to baseline and the
patient’s symptoms transiently resolved. A 12-lead ECG
was obtained (Fig. 1). Approximately 45 minutes later, the
patient became acutely unresponsive with minimal mea-
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surable LVAD flow and no palpable pulse. The LVAD
was immediately disconnected from the external electric
power source and manual mechanical pumping of the
LVAD was initiated, but without achieving a palpable
peripheral pulse. Despite vigorous resuscitative efforts
with intravenous inotropic/vasopressor agents, a pulse
could not be restored and the patient died.
Postmortem examination revealed markedly dilated
right and left ventricular chambers consistent with the
preoperative diagnosis. All suture lines were intact with
no evidence of hemorrhage, perforation, or infection. The
valved conduits and pump chamber were intact without
evidence of thrombus or valve disruption. The pump
chamber that houses the electric motor and cam assembly
Fig. 1. Standard 12-lead ECG obtained prior to device failure demonstrating current bursts in synchrony
with the LVAD. Native QRS complexes are noted (arrows).
Fig. 2. A, LVAD motor chamber showing clotted blood over the stator, the magnet, and cams, as well as
over and under the retaining screw. The hardened blood clot effectively adheres the movable magnet and
cams to the motor chamber housing and stator, thus impeding any rotation of the cams (0.53). B, Back
surface of the pusher plate showing clotted dry blood on the plate and ramps (0.53).
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was encased with dried blood, which effectively prevented
the pusher plate from functioning. Careful examination of
the drive line failed to identify a site of perforation
through which blood may have entered the system (Fig.
2).
Comment. Implantable LVADs have progressed tech-
nologically to a point where they can provide improved
survival for patients awaiting transplantation and will also
provide a long-term alternative to heart transplantation.
The need for this therapy is increasing every year as the
number of patients with refractory heart failure increases.
Currently available implantable LVADs are either elec-
trically or pneumatically driven, with the former providing
greater patient mobility. The HeartMate pneumatic
LVAD has been extremely reliable, with few reported
device-related failures. These have included a loosening
of the outflow connector and erosion of the Dacron fabric
within the inflow conduit, both of which have been
rectified by design modifications.3-5 This level of device
reliability contributed greatly to the Food and Drug
Administration’s approval of the pneumatic HeartMate
LVAD as a bridge to transplantation.
The VE HeartMate System operates on 12 volts of
direct current and draws approximately 1 ampere of
current under normal load conditions. However, with
increased resistance to pumping, the motor can draw up to
5 amperes of current in bursts. The pattern of high-
current bursts observed on this patient’s ECG in syn-
chrony with the pump before device failure may be
explained by two possible mechanisms. First, the in-
creased resistance encountered by the motor and cam
assembly as blood entered the chamber may have resulted
in an increased power draw reflected on the external ECG
pattern. Alternatively, blood in the motor compartment
may have resulted in a current leak reflected on the ECG.
Regardless, the pattern observed on this patient’s ECG
before device failure correlates clinically with the finding
of blood within the actuating mechanism with resultant
malfunction. To our knowledge, this finding has not been
previously reported and, when observed, should alert the
clinician to potential impending device failure. It is sug-
gested that the presence of this finding in a patient
supported on the HeartMate VE System should prompt
immediate interrogation of the device by means of the
external console. Further, consideration should be given
to urgent surgical intervention.
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